Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04731077 · ClinicalTrials.gov registry record · NA
Avenir Complete Post-Market Clinical Follow-Up Study
A NA study of Osteoarthritis, Hip and Avascular Necrosis of the Femoral Head, sponsored by Zimmer Biomet.
- Active
- Registry status
- NA
- Development phase
- 275
- Enrollment target
- 9
- Study locations
NCT04731077 is a NA study of Osteoarthritis, Hip and Avascular Necrosis of the Femoral Head that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 275 participants, below the 1,260-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (78% lower). The trial reports 9 study locations across 6 states.
The verdict
NCT04731077, a NA study of Osteoarthritis, Hip and Avascular Necrosis of the Femoral Head, is active but no longer recruiting, sponsored by Zimmer Biomet.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 275 participants
- Enrollment target
- 9
- Study locations
Study Summary
The main objectives of this study are to confirm the long-term safety, performance and clinical benefits the Avenir Complete femoral stem and its instrumentation when used in primary total, hemi, and revision hip arthroplasty.
Conditions Studied
Interventions
- DEVICE Avenir Complete Femoral Stem
Study Locations (9)
Other
- Copenhagen University Hospital, Hvidovre - Copenhagen
- Okayama City Hospital - Okayama
- Sykehuset Innlandet HF - Tynset
- Sahlgrenska University Hospital - Molndal - Mölndal
Mississippi
- Mississippi Sports Medicine and Orthopaedic Center PLLC - Jackson
Missouri
- Heartland Regional Medical Center d.b.a. Mosaic Life Care - Saint Joseph
Oregon
- Orthopedic & Fracture Clinic, PC - Portland
Tokyo
- Nissan Tamagawa Hospital - Setagaya-Ku
South Holland
- Ikazia Ziekenhuis - Rotterdam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2021-09-27 |
| Est. Completion | 2036-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04731077
The ClinicalTrials.gov registry entry for NCT04731077 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 275 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,260-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (78% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Osteoarthritis, Hip appearing as the primary indexed condition, and to 1 intervention - of which Avenir Complete Femoral Stem is the first listed.
NCT04731077 reports 9 study locations spanning 6 distinct geographic areas - top geographies include Other, Mississippi, Missouri.
Frequently Asked Questions
What is clinical trial NCT04731077 about?
NCT04731077 is a clinical study titled "Avenir Complete Post-Market Clinical Follow-Up Study". The main objectives of this study are to confirm the long-term safety, performance and clinical benefits the Avenir Complete femoral stem and its instrumentation when used in primary total, hemi, and revision hip arthroplasty.
What is the current status of trial NCT04731077?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 275 participants. The study started on 2021-09-27. Estimated completion is 2036-06-01.
What conditions does trial NCT04731077 study?
This clinical trial studies the following conditions: Osteoarthritis, Hip, Avascular Necrosis of the Femoral Head, Avascular Necrosis of Hip, Post-traumatic; Arthrosis.
What interventions are being tested in trial NCT04731077?
The interventions under investigation include: Avenir Complete Femoral Stem (DEVICE).
Who is sponsoring clinical trial NCT04731077?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04731077 being conducted?
This trial has 9 study locations across Mississippi, Missouri, Oregon, Tokyo, South Holland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Hip
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Effectiveness of the HIT Reverse HRS
RECRUITING · NA
-
Non-invasive Evaluation of Upper and Lower Body Function With Showmotion
RECRUITING · NA
-
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
RECRUITING · NA
-
Outcomes of Low-Impact Exercise Program for People With Ankle, Knee, and/or Hip Pain
RECRUITING · NA
-
Early Feasibility Study of Cartilage Defect Repair
RECRUITING · NA
-
Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis
RECRUITING · NA
Explore more on PlainTrial
Osteoarthritis, Hip
All registered trials for this condition
Avascular Necrosis of the Femoral Head
All registered trials for this condition
Mississippi
All trials with a study site in Mississippi
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.